Abstract
The tumour suppressor p53 has been shown to regulate RNA polymerase (pol) III transcription both in vitro and in vivo. We have characterized the regions of p53 that contribute to this effect. Repression of pol III transcription in vivo does not require residues 13–19 near the N-terminus of p53 that are highly conserved through evolution. However, amino acids 22 and 23 in the adjacent transactivation domain do contribute to the inhibition of pol III activity. Deletions within the central DNA-binding core domain (residues 102–292) of p53 can entirely abolish the repression function in these assays, despite the fact that pol III templates contain no recognized p53 binding site. Deletion or substitution within the C-terminal domain of p53 can also compromise its ability to repress pol III activity in vitro and in transfected cells. These observations reveal that repression of pol III transcription is a complex function involving multiple regions of p53 extending throughout much of the protein.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abelson HT, Johnson LF, Penman S, Green H . 1974 Cell 1: 161–165
Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K . 1997 Cell 89: 1175–1184
Brown TRP, Scott PH, Stein T, Winter AG, White RJ . 2000 Gene Expr. 9: 15–28
Cairns CA, White RJ . 1998 EMBO J. 17: 3112–3123
Chang J, Kim DH, Lee SW, Choi KY, Sung YC . 1995 J. Biol. Chem. 270: 25014–25019
Chen KV, Ueda K, Pastan I, Gottesman MM . 1992 Science 255: 459–462
Chesnokov I, Chu WM, Botchan MR, Schmid CW . 1996 Mol. Cell. Biol. 16: 7084–7088
Cox LS, Lane DP . 1995 Bioessays 17: 501–508
Crook T, Marston NJ, Sara EA, Vousden KH . 1994 Cell 79: 817–827
Dean N, Berk AJ . 1988 Mol. Cell. Biol. 8: 3017–3025
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825
Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C . 1992 Nature 358: 83–86
Farmer G, Colgan J, Nakatani Y, Manley JL, Prives C . 1996a Mol. Cell. Biol. 16: 4295–4304
Farmer G, Friedlander P, Colgan J, Manley JL, Prives C . 1996b Nucleic Acids Res. 24: 4281–4288
Fields S, Jang SK . 1990 Science 249: 1046–1049
Ginsberg D, Mechta F, Yaniv M, Oren M . 1991 Proc. Natl. Acad. Sci. USA 88: 9979–9983
Hollstein M, Rice K, Greenblatt MS, Soussi T, Fucks R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, Harris CC . 1994 Nucleic Acids Res. 22: 3551–3555
Hollstein M, Sidransky D, Vogelstein B, Harris CC . 1991 Science 253: 49–53
Hong T-M, Chen JJW, Peck K, Yang P-C, Wu C-W . 2001 J. Biol. Chem. 276: 1510–1515
Horikoshi N, Usheva A, Chen J, Levine AJ, Weinmann R, Shenk T . 1995 Mol. Cell. Biol. 15: 227–234
Hupp TR, Meek DW, Midgley CA, Lane DP . 1992 Cell 71: 875–886
Jeffrey PD, Gorina S, Pavletich NP . 1995 Science 267: 1498–1502
Kassavetis GA, Joazeiro CAP, Pisano M, Geiduschek EP, Colbert T, Hahn S, Blanco JA . 1992 Cell 71: 1055–1064
Kern S, Kinzler K, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B . 1991 Science 252: 1708–1711
Ko LJ, Prives C . 1996 Genes Dev. 10: 1054–1072
Kubbutat MHG, Ludwig RL, Ashcroft M, Vousden KH . 1998 Mol. Cell. Biol. 18: 5690–5698
Levine AJ . 1997 Cell 88: 323–331
Lin J, Chen J, Elenbaas B, Levine AJ . 1994 Genes Dev. 8: 1235–1246
Lobo SM, Tanaka M, Sullivan ML, Hernandez N . 1992 Cell 71: 1029–1040
Lu H, Levine AJ . 1995 Proc. Natl. Acad. Sci. USA 92: 5154–5158
Mack DH, Vartikar J, Pipas JM, Laimins LA . 1993 Nature 363: 281–283
Marston NJ, Ludwig RL, Vousden KH . 1998 Oncogene 16: 3123–3131
Mauck JC, Green H . 1974 Cell 3: 171–177
Molinari M, Okorokov AL, Milner J . 1996 Oncogene 13: 2077–2086
Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ, George DL . 1999 Genes Dev. 13: 2490–2501
Murphy M, Hunman A, Levine AJ . 1996 Genes Dev. 10: 2971–2980
Neufeld TP, Edgar BA . 1998 Curr. Opin. Cell. Biol. 10: 784–790
Okorokov AL, Milner J . 1999 Mol. Cell. Biol. 19: 7501–7510
Okorokov AL, Ponchel F, Milner J . 1997 EMBO J. 16: 6008–6017
Paule MR, White RJ . 2000 Nucleic Acids Res. 28: 1283–1298
Pietenpol JA, Tokino T, Thiagalingam S, El-Deiry WS, Kinzler KW, Vogelstein BS . 1994 Proc. Natl. Acad. Sci. USA 91: 1998–2002
Ragimov N, Krauskopf A, Navot N, Rotter V, Oren M, Aloni Y . 1993 Oncogene 8: 1183–1193
Raycroft L, Wu H, Lozano G . 1990 Science 249: 1049–1051
Sang B-C, Chen J-Y, Minna J, Barbosa MS . 1994 Oncogene 9: 853–859
Scott PH, Cairns CA, Sutcliffe JE, Alzuherri HM, Mclees A, Winter AG, White RJ . 2001 J. Biol. Chem. 276: 1005–1014
Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine AJ, Shenk T . 1992 Proc. Natl. Acad. Sci. USA 89: 12028–12032
Shen Y, Shenk T . 1994 Proc. Natl. Acad. Sci. USA 91: 8940–8944
Shew J-Y, Lin BT-Y, Chen P-L, Tseng BY, Yang-Feng TL, Lee W-H . 1990 Proc. Natl. Acad. Sci. USA 87: 6–10
Simmen KA, Bernues J, Lewis JD, Mattaj IW . 1992 Nucleic Acids Res. 20: 5889–5898
Sionov RV, Haupt Y . 1999 Oncogene 18: 6145–6157
Soussi T, Caron de Fromentel C, May P . 1990 Oncogene 5: 945–952
Stein T, Crighton D, Boyle JM, Varley JM, White RJ . 2002 Oncogene 21: 2961–2970
Sturzbecher HW, Brain R, Addison C, Rudge K, Remm M, Grimaldi M, Kennan E, Jenkins JR . 1992 Oncogene 7: 1513–1523
Subler MA, Martin DW, Deb S . 1994 Oncogene 9: 1351–1359
Sutcliffe JE, Brown TRP, Allison SJ, Scott PH, White RJ . 2000 Mol. Cell. Biol. 20: 9192–9202
Taggart AKP, Fisher TS, Pugh BF . 1992 Cell 71: 1015–1028
Thut CJ, Chen J-L, Klemm R, Tjian R . 1995 Science 267: 100–104
Vogelstein B, Lane D, Levine AJ . 2000 Nature 408: 307–310
Vousden KH . 2000 Cell 103: 691–694
White RJ . 1998a RNA Polymerase III Transcription Berlin: Springer-Verlag
White RJ . 1998b Int. J. Oncol. 12: 741–748
White RJ, Gottlieb TM, Downes CS, Jackson SP . 1995a Mol. Cell. Biol. 15: 6653–6662
White RJ, Gottlieb TM, Downes CS, Jackson SP . 1995b Mol. Cell. Biol. 15: 1983–1992
White RJ, Jackson SP . 1992 Cell 71: 1041–1053
White RJ, Stott D, Rigby PWJ . 1989 Cell 59: 1081–1092
White RJ, Trouche D, Martin K, Jackson SP, Kouzarides T . 1996 Nature 382: 88–90
Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B . 1999 Proc. Natl. Acad. Sci. USA 96: 14517–14522
Zambetti G, Bargonetti J, Walker K, Prives C, Levine A . 1992 Genes Dev. 6: 1143–1152
Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH, Levine AJ . 2000 Genes Dev. 14: 981–993
Acknowledgements
We wish to thank Arnold Berk, Sheila Graham, Arnold Levine and Karen Vousden for plasmids. This work was funded by Yorkshire Cancer Research to J Milner and by project grant SP2314/0102 to RJ White from Cancer Research UK (formerly the Cancer Research Campaign). RJ White is a Jenner Research Fellow of the Lister Institute of Preventive Medicine.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stein, T., Crighton, D., Warnock, L. et al. Several regions of p53 are involved in repression of RNA polymerase III transcription. Oncogene 21, 5540–5547 (2002). https://doi.org/10.1038/sj.onc.1205739
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205739
Keywords
This article is cited by
-
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia
Leukemia (2015)
-
RNA polymerase III transcription in cancer: the BRF2 connection
Molecular Cancer (2011)
-
Transcriptional regulation by p53: one protein, many possibilities
Cell Death & Differentiation (2006)
-
RNA polymerases I and III, growth control and cancer
Nature Reviews Molecular Cell Biology (2005)
-
RNA polymerase III transcription and cancer
Oncogene (2004)